Cargando…

The Acute Chest Syndrome in Cameroonian children living with sickle cell disease

BACKGROUND: Although sub-Saharan Africa (SSA) is particularly affected by sickle cell disease (SCD), there is dearth of research on this topic in the region, specifically targeting the magnitude of SCD-related complications. We therefore conducted this study to determine the burden of acute chest sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Nansseu, Jobert Richie N., Alima Yanda, Anastasie Nicole, Chelo, David, Tatah, Sandra A., Mbassi Awa, Hubert D., Seungue, Judith, Koki, Paul Olivier N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578678/
https://www.ncbi.nlm.nih.gov/pubmed/26391669
http://dx.doi.org/10.1186/s12887-015-0454-0
_version_ 1782391151476604928
author Nansseu, Jobert Richie N.
Alima Yanda, Anastasie Nicole
Chelo, David
Tatah, Sandra A.
Mbassi Awa, Hubert D.
Seungue, Judith
Koki, Paul Olivier N.
author_facet Nansseu, Jobert Richie N.
Alima Yanda, Anastasie Nicole
Chelo, David
Tatah, Sandra A.
Mbassi Awa, Hubert D.
Seungue, Judith
Koki, Paul Olivier N.
author_sort Nansseu, Jobert Richie N.
collection PubMed
description BACKGROUND: Although sub-Saharan Africa (SSA) is particularly affected by sickle cell disease (SCD), there is dearth of research on this topic in the region, specifically targeting the magnitude of SCD-related complications. We therefore conducted this study to determine the burden of acute chest syndrome (ACS) and describe its clinical and therapeutic aspects among SCD children in Cameroon, a SSA country. METHODS: This was a retrospective study carried-out from September 2013 to June 2014 at the SCD unit of the Mother and Child Centre of the Chantal Biya Foundation, a pediatric reference centre in Yaoundé, Cameroon. We enrolled all SCD children with confirmed diagnosis of ACS, and recorded their clinical presentation at admission along with their evolution during hospitalization. RESULTS: Twenty one cases of ACS were identified during the study period, from 338 hospitalizations of children with SCD. Ages ranged from 11 months to 16 years with a mean (standard deviation) of 5.5 (3.4) years, and a male/female sex ratio of 3.2/1. We noticed relatively low levels of HbF, from 6.4 to 21.9 % with a mean of 14.6 % (6.0 %). The three main symptoms at admission were fever (90.5 %), cough (81 %) and chest pains (28.6 %). Two patients (9.5 %) developed ACS 2 days after admission. The mean values of leukocytes, neutrophils, serum CRP, serum LDH and hemoglobin were respectively 32479.4 (17862.3)/mm(3), 23476 (11543.7)/mm(3), 228.2 (132.6) mg/l, 3452.3 (2916.3) IU/l and 6.5 (1.2) g/dl. The main localizations of radiological alveolar consolidations were the lower lobes (90.5 %). Treatment associated broad-spectrum antibiotics (100 %), hydration (100 %), analgesics (43.2 %), whole blood transfusion (66.7 %), and oxygen supplementation (33.3 %). Blood transfusion significantly improved hemoglobin level (p = 0.039). The duration of hospitalization, the mean of which was 6.8 (3.1) days, was influenced by none of the tested variables (all p values > 0.05). CONCLUSION: ACS is frequent among SCD children in our milieu. Its etiologies seem to be multifactorial. Patients’ parents should be educated to recognize early signs and symptoms of the disease, and consult rapidly. Additionally, clinicians must be trained to diagnose ACS, and manage it promptly and efficiently to avoid its related catastrophic consequences.
format Online
Article
Text
id pubmed-4578678
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45786782015-09-23 The Acute Chest Syndrome in Cameroonian children living with sickle cell disease Nansseu, Jobert Richie N. Alima Yanda, Anastasie Nicole Chelo, David Tatah, Sandra A. Mbassi Awa, Hubert D. Seungue, Judith Koki, Paul Olivier N. BMC Pediatr Research Article BACKGROUND: Although sub-Saharan Africa (SSA) is particularly affected by sickle cell disease (SCD), there is dearth of research on this topic in the region, specifically targeting the magnitude of SCD-related complications. We therefore conducted this study to determine the burden of acute chest syndrome (ACS) and describe its clinical and therapeutic aspects among SCD children in Cameroon, a SSA country. METHODS: This was a retrospective study carried-out from September 2013 to June 2014 at the SCD unit of the Mother and Child Centre of the Chantal Biya Foundation, a pediatric reference centre in Yaoundé, Cameroon. We enrolled all SCD children with confirmed diagnosis of ACS, and recorded their clinical presentation at admission along with their evolution during hospitalization. RESULTS: Twenty one cases of ACS were identified during the study period, from 338 hospitalizations of children with SCD. Ages ranged from 11 months to 16 years with a mean (standard deviation) of 5.5 (3.4) years, and a male/female sex ratio of 3.2/1. We noticed relatively low levels of HbF, from 6.4 to 21.9 % with a mean of 14.6 % (6.0 %). The three main symptoms at admission were fever (90.5 %), cough (81 %) and chest pains (28.6 %). Two patients (9.5 %) developed ACS 2 days after admission. The mean values of leukocytes, neutrophils, serum CRP, serum LDH and hemoglobin were respectively 32479.4 (17862.3)/mm(3), 23476 (11543.7)/mm(3), 228.2 (132.6) mg/l, 3452.3 (2916.3) IU/l and 6.5 (1.2) g/dl. The main localizations of radiological alveolar consolidations were the lower lobes (90.5 %). Treatment associated broad-spectrum antibiotics (100 %), hydration (100 %), analgesics (43.2 %), whole blood transfusion (66.7 %), and oxygen supplementation (33.3 %). Blood transfusion significantly improved hemoglobin level (p = 0.039). The duration of hospitalization, the mean of which was 6.8 (3.1) days, was influenced by none of the tested variables (all p values > 0.05). CONCLUSION: ACS is frequent among SCD children in our milieu. Its etiologies seem to be multifactorial. Patients’ parents should be educated to recognize early signs and symptoms of the disease, and consult rapidly. Additionally, clinicians must be trained to diagnose ACS, and manage it promptly and efficiently to avoid its related catastrophic consequences. BioMed Central 2015-09-21 /pmc/articles/PMC4578678/ /pubmed/26391669 http://dx.doi.org/10.1186/s12887-015-0454-0 Text en © Nansseu et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Nansseu, Jobert Richie N.
Alima Yanda, Anastasie Nicole
Chelo, David
Tatah, Sandra A.
Mbassi Awa, Hubert D.
Seungue, Judith
Koki, Paul Olivier N.
The Acute Chest Syndrome in Cameroonian children living with sickle cell disease
title The Acute Chest Syndrome in Cameroonian children living with sickle cell disease
title_full The Acute Chest Syndrome in Cameroonian children living with sickle cell disease
title_fullStr The Acute Chest Syndrome in Cameroonian children living with sickle cell disease
title_full_unstemmed The Acute Chest Syndrome in Cameroonian children living with sickle cell disease
title_short The Acute Chest Syndrome in Cameroonian children living with sickle cell disease
title_sort acute chest syndrome in cameroonian children living with sickle cell disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578678/
https://www.ncbi.nlm.nih.gov/pubmed/26391669
http://dx.doi.org/10.1186/s12887-015-0454-0
work_keys_str_mv AT nansseujobertrichien theacutechestsyndromeincameroonianchildrenlivingwithsicklecelldisease
AT alimayandaanastasienicole theacutechestsyndromeincameroonianchildrenlivingwithsicklecelldisease
AT chelodavid theacutechestsyndromeincameroonianchildrenlivingwithsicklecelldisease
AT tatahsandraa theacutechestsyndromeincameroonianchildrenlivingwithsicklecelldisease
AT mbassiawahubertd theacutechestsyndromeincameroonianchildrenlivingwithsicklecelldisease
AT seunguejudith theacutechestsyndromeincameroonianchildrenlivingwithsicklecelldisease
AT kokipauloliviern theacutechestsyndromeincameroonianchildrenlivingwithsicklecelldisease
AT nansseujobertrichien acutechestsyndromeincameroonianchildrenlivingwithsicklecelldisease
AT alimayandaanastasienicole acutechestsyndromeincameroonianchildrenlivingwithsicklecelldisease
AT chelodavid acutechestsyndromeincameroonianchildrenlivingwithsicklecelldisease
AT tatahsandraa acutechestsyndromeincameroonianchildrenlivingwithsicklecelldisease
AT mbassiawahubertd acutechestsyndromeincameroonianchildrenlivingwithsicklecelldisease
AT seunguejudith acutechestsyndromeincameroonianchildrenlivingwithsicklecelldisease
AT kokipauloliviern acutechestsyndromeincameroonianchildrenlivingwithsicklecelldisease